2023 May;168:105631
Kuhn H, Banthiya S, Van Leyen K
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (surmount-2): A double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
Demjaha A, Lappin JM, Stahl D, Patel MX, MacCabe JH, Howes OD, et al
Hims & Hers is introducing the Service Appreciation Initiative to give eligible U According to the World Health Organization (WHO), around 70% of American adults have obesity or are overweight and at least 2.8 million people die each year due to being overweight or having obesity